SOPHiA GENETICS SA
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of SOPHiA GENETICS SA generated cash of -$48,575,000, which is more than the previous year. Cash used in financing activities reached the amount of -$2,817,000 last year. Net change in cash is therefore -$38,054,000.

Cash Flow

SOPHiA GENETICS SA (NASDAQ:SOPH): Cash Flow
2019 -31.68M -3.03M -1.02M
2020 -31.73M -24.32M 107.04M
2021 -57.93M -56.93M 237.77M
2022 -70.09M 41.97M -1.56M
2023 -48.57M 8.32M -2.81M

SOPH Cash Flow Statement (2019 – 2023)

2023 2022 2021 2020 2019
Cash at beginning of period
161.30M192.96M74.62M18.06M53.90M
Operating activities
Net income
-78.98M-87.58M-73.50M-41.22M-33.62M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
8.33M5.57M3.60M2.39M1.91M
Stock-based compensation expense
15.24M13.61M8.51M1.35M717K
Deferred income tax benefit 15.24M13.61M8.51M1.35M717K
Changes in operating assets and liabilities:
Accounts receivable, net
-6.5M1.33M1.80M1.11M-4.35M
Inventories
-874K-200K-2.33M536K-862K
Accounts payable
6.87M-1.42M8.98M-185K5.60M
Cash generated by operating activities
-48.57M-70.09M-57.93M-31.73M-31.68M
Investing activities
Purchases Of Investments
0-26.17M-72.14M-21.11M0
Investments In Property Plant And Equipment
-1.49M-10.38M-6.67M-3.20M-3.03M
Acquisitions Net
06.28M3.98M00
Cash generated by investing activities
8.32M41.97M-56.93M-24.32M-3.03M
Financing activities
Common Stock Issued
226K0231.31M107.64M1.76M
Payments for dividends
00000
Repurchases of common stock
00000
Repayments of term debt
-3.04M0-4.08M-17.50M-2.78M
Cash used in financing activities
-2.81M-1.56M237.77M107.04M-1.02M
Net Change In Cash
-38.05M-31.65M118.33M56.55M-35.83M
Cash at end of period
123.25M161.30M192.96M74.62M18.06M
Data sourceData sourceData source